This genetic study identifies a novel EGR2 variant associated with Charcot-Marie-Tooth (CMT) disease, particularly when co-expressed with a TNF-α T49M polymorphism. These combined mutations disrupt normal Schwann cell function and myelination.
The findings suggest a gene-environment interaction where inflammatory pathways exacerbate genetic predispositions to neuropathies. Targeting TNF-α signaling could mitigate the impact of such mutations on disease progression.
This research enhances the understanding of genetic susceptibility in peripheral neuropathies and opens avenues for personalized therapeutic strategies.
